Surface Oncology, Inc.
SURF · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $51 | $56 | $175 | $47 |
| Short-Term Investments | $74 | $98 | $0 | $58 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | -$0 | -$1 | $0 | -$0 |
| Other Curr. Assets | $4 | $3 | $5 | $3 |
| Total Curr. Assets | $129 | $157 | $181 | $108 |
| Property Plant & Equip (Net) | $29 | $32 | $35 | $22 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $31 | $34 | $37 | $24 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $160 | $191 | $217 | $132 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $2 | $3 |
| Short-Term Debt | $6 | $5 | $6 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $10 | $9 | $39 |
| Other Curr. Liab. | $10 | $13 | $10 | $8 |
| Total Curr. Liab. | $16 | $20 | $18 | $19 |
| LT Debt | $50 | $52 | $44 | $22 |
| Deferred Rev, NC | $0 | $0 | $0 | $34 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | -$5 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $50 | $52 | $44 | $56 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $67 | $72 | $61 | $75 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$204 | -$141 | -$62 | -$122 |
| AOCI | -$1 | -$0 | $0 | $0 |
| Other Equity | $299 | $260 | $218 | $178 |
| Total Equity | $93 | $119 | $156 | $57 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $160 | $191 | $217 | $132 |
| Net Debt | $5 | $1 | -$126 | -$22 |